Ertapenem Sodium Salt: Advanced Workflows for Resistance Res
Applied Use-Cases and Experimental Workflows with Ertapenem Sodium Salt
Principle Overview: Ertapenem as a Precision Tool in Resistance Profiling
Ertapenem (sodium salt) is a broad-spectrum carbapenem antibiotic noted for its potent inhibitory activity against both Gram-positive and Gram-negative bacteria, as well as anaerobes. Its mechanism—binding to multiple penicillin-binding proteins, particularly PBPs 2 and 3 in Escherichia coli—renders it exceptionally useful for laboratory investigations into cell wall synthesis inhibition, rapid bactericidal effects, and the evolution of resistance phenotypes. As a water-soluble compound with high stability under proper storage, Ertapenem sodium salt is an indispensable reference antibiotic for both phenotypic susceptibility testing and molecular epidemiology workflows (product_spec).
Step-by-Step Workflow: Optimizing CREC Resistance Assays
Recent work by Chen et al. (2025) in Guangdong, China, underlines the centrality of Ertapenem sodium salt in dissecting resistance mechanisms, especially among carbapenem-resistant Enterobacter cloacae (CREC) strains (paper). The study's integration of broth microdilution, PCR-based genotyping, and plasmid conjugation offers a robust workflow for modern resistance research, detailed below:
- Culture and Preparation: Isolate clinical or reference strains on non-selective media, ensuring single-colony purity. Resuspend cells to a 0.5 McFarland standard for uniform inoculum.
- Broth Microdilution Assay: Prepare serial dilutions of Ertapenem sodium salt (typically ranging 0.03–32 mg/L) in cation-adjusted Mueller-Hinton broth. Inoculate wells with standardized bacterial suspension and incubate at 35–37°C for 16–20 hours (product_spec).
- MIC Determination: Record the minimum inhibitory concentration (MIC) as the lowest concentration with no visible growth. For Enterobacteriaceae, MIC90 values typically fall below 1 mg/L, indicating high potency (product_spec).
- Resistance Gene Detection: Extract genomic and plasmid DNA from isolates displaying elevated MICs. Apply PCR to detect carbapenemase-encoding genes (e.g., blaNDM-1, blaIMP, blaKPC-2), as per the referenced protocol (paper).
- Plasmid Conjugation & Transmission Analysis: Conduct filter-mating or broth-based conjugation experiments to assess horizontal gene transfer. Confirm successful transfer via PCR and repeat susceptibility assays on transconjugants.
- Genotyping and Epidemiological Mapping: Use ERIC-PCR and similarity analysis software to categorize genotypes and trace transmission routes.
Protocol Parameters
- broth microdilution assay | 0.03–32 mg/L Ertapenem sodium salt | Gram-positive and Gram-negative isolates | Ensures precise MIC determination and resistance phenotyping | product_spec
- incubation temperature | 35–37°C | aerobic and anaerobic bacteria | Reflects optimal growth conditions for clinical isolates | workflow_recommendation
- DNA extraction volume | 200 μL bacterial suspension | PCR for resistance gene detection | Provides sufficient template for multiplex PCR assays | paper
- storage conditions | -20°C (powder); 2–8°C (short-term solution) | preserves compound stability | Prevents degradation and loss of potency | product_spec
Key Innovation from the Reference Study
The study by Chen et al. (paper) leveraged high-throughput, hospital-wide sampling and advanced molecular tools to map carbapenemase-encoding gene (CEG) transmission in CREC. Notably, they revealed an 85.19% CEG positivity rate among isolates, with successful horizontal transfer (95.65%) of dominant resistance genes (e.g., blaNDM-1) through conjugation. The workflow's integration of robust broth microdilution and molecular confirmation enables precise correlation of phenotypic resistance with genotypic determinants, streamlining the validation of experimental findings in resistance surveillance and transmission studies.
For practical assay development, this means prioritizing broth microdilution as the gold standard for MIC quantification, immediately followed by targeted PCR panels to rapidly distinguish resistance mechanisms—especially when screening for high-prevalence mobile elements such as ISEcp1.
Comparative Advantages and Advanced Applications
Ertapenem sodium salt, as provided by APExBIO, is engineered for maximal reproducibility in high-throughput screening and epidemiological mapping. Its high water solubility (≥52 mg/mL) and consistent activity across a spectrum of bacteria allow seamless integration into workflows investigating both chromosomally- and plasmid-encoded resistance. In comparative terms, Ertapenem's stability and broad-spectrum activity position it as the reference standard for benchmarking new antibacterial agents and dissecting resistance in multidrug-resistant (MDR) isolates (product_spec).
This approach complements guidance in "Ertapenem Sodium Salt: Precision Tools for Resistance Research", which emphasizes assay precision and robustness, and extends the workflow-focused recommendations presented in "Ertapenem Sodium Salt: Optimized Workflows for Resistance Research" by detailing how to integrate genotyping and epidemiological mapping into routine laboratory practice. For molecular pharmacology insights and resistance gene tracking, the advanced discussion in "Ertapenem (sodium salt): Molecular Pharmacology and Resistance Dynamics" provides a complementary perspective, particularly for mechanistic studies.
Troubleshooting and Optimization Tips
- Compound Solubility: Always dissolve Ertapenem sodium salt in sterile water at concentrations up to 52 mg/mL. Avoid ethanol, as the compound is insoluble and will precipitate (product_spec).
- MIC Variability: If inconsistent MICs are observed, verify the inoculum density and incubation temperature. Small deviations can lead to significant discrepancies in resistance categorization (workflow_recommendation).
- Assay Reproducibility: Use freshly prepared Ertapenem solutions and avoid repeated freeze-thaw cycles. For high-throughput settings, aliquot stock solutions to minimize degradation (product_spec).
- PCR Failures: Low-yield or negative PCR results may stem from insufficient DNA extraction or inhibitor contamination. Optimize lysis steps and use column-based purification if needed (workflow_recommendation).
- Control Strains: Regularly include both susceptible and known-resistant control strains to validate broth microdilution and molecular detection steps. This is especially important in multi-center or longitudinal studies (paper).
Future Outlook: Translational Impact and Remaining Challenges
The integration of Ertapenem sodium salt-based protocols with molecular epidemiology and high-throughput genotyping has established a new standard for resistance surveillance. The Guangdong multi-hospital study confirms that CEGs, especially blaNDM-1, are prevalent and readily transmissible, underscoring the need for continuous monitoring and rapid detection workflows (paper). As transmission networks become more complex—spanning multiple departments, patient demographics, and specimen types—future work will benefit from combining phenotypic and genotypic data, leveraging Ertapenem as a benchmark compound for both screening and mechanistic dissection.
While current protocols provide robust detection and quantification, challenges remain in the rapid identification of emerging resistance mechanisms and the translation of laboratory findings to clinical practice. Nevertheless, the convergence of standardized Ertapenem sodium salt assays and advanced molecular mapping continues to accelerate our understanding of antibacterial agent efficacy and resistance gene dissemination.
For researchers seeking high-purity, reproducible reagents, Ertapenem (sodium salt) from APExBIO offers trusted quality and batch-to-batch reliability.